GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IMRIS Inc (GREY:IMRSQ) » Definitions » FCF Margin %

IMRIS (IMRSQ) FCF Margin % : -21.66% (As of Dec. 2014)


View and export this data going back to 2010. Start your Free Trial

What is IMRIS FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. IMRIS's Free Cash Flow for the three months ended in Dec. 2014 was $-2.07 Mil. IMRIS's Revenue for the three months ended in Dec. 2014 was $9.56 Mil. Therefore, IMRIS's FCF Margin % for the quarter that ended in Dec. 2014 was -21.66%.

As of today, IMRIS's current FCF Yield % is 0.00%.

The historical rank and industry rank for IMRIS's FCF Margin % or its related term are showing as below:

IMRSQ' s FCF Margin % Range Over the Past 10 Years
Min: -46.94   Med: 0   Max: 0
Current: -46.94


IMRSQ's FCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -7.14 vs IMRSQ: -46.94


IMRIS FCF Margin % Historical Data

The historical data trend for IMRIS's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMRIS FCF Margin % Chart

IMRIS Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
FCF Margin %
Get a 7-Day Free Trial Premium Member Only -22.89 -41.68 -39.44 -108.57 -46.94

IMRIS Quarterly Data
Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -149.56 -3.90 -90.04 -105.98 -21.66

Competitive Comparison of IMRIS's FCF Margin %

For the Medical Devices subindustry, IMRIS's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IMRIS's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IMRIS's FCF Margin % distribution charts can be found below:

* The bar in red indicates where IMRIS's FCF Margin % falls into.



IMRIS FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

IMRIS's FCF Margin for the fiscal year that ended in Dec. 2014 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2014 )/Revenue (A: Dec. 2014 )
=-13.56/28.891
=-46.94 %

IMRIS's FCF Margin for the quarter that ended in Dec. 2014 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2014 )/Revenue (Q: Dec. 2014 )
=-2.07/9.558
=-21.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IMRIS FCF Margin % Related Terms

Thank you for viewing the detailed overview of IMRIS's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


IMRIS (IMRSQ) Business Description

Traded in Other Exchanges
N/A
Address
100-1370 Sony Place, Winnipeg, MB, CAN, R3T 1N5
IMRIS Inc designs, manufactures and markets Image-guided therapy systems that improves the effectiveness of therapy delivery. Its main product is the Visius surgical theater. The company provides its products to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular and cardiovascular markets. The firm is focused on bringing enhanced visualization to the point of therapy delivery and is spread across Canada, United States, Europe and the Middle East and Asia-Pacific.

IMRIS (IMRSQ) Headlines

No Headlines